- product name: marbodad 2%
- dosage form: injection
- packaging: 100 ml
Composition: Each 1ml contains:
Marbofloxacin 20 mg
Pharmacological Properties Marbofloxacin is a synthetic, bactericidal antimicrobial, belonging to the fluoroquinolone group, which acts by inhibition of DNA gyrase. It has a broad-spectrum activity in vitro against gram-negative bacteria (Pasteurella multocida, Mannheimia haemolytica, Histophilus somni, E.coli) and against gram-positive bacteria (in particular Staphylococcus).
Resistance to Streptococcus may occur.
Target species: Calves, Dogs and Cats.
Indications: Marbodad 2% injection used for :
In Calves: Treatment of respiratory infections caused by sensitive strains of Histophilus somni, Mannheimia haemolytica and Pasteurella multocida.
In Dogs: Treatment of infected wounds and abscesses. Treatment of lower urinary tract infections due to Escherichia coli and Proteus mirabilis. Prevention of surgical infections due to Staphylococcus intermedius, Escherichia coli and Pseudomonas aeruginosa.
In Cats: Treatment of infected wounds and abscesses. Prevention of surgical infections due to Staphylococcus intermedius, Escherichia coli and Pseudomonas aeruginosa.
Dosage:
Calves: The recommended dosage is : 2 mg Marbofloxacin /kg b.w (1 ml Marbodad 2% injection /10 kg b.w) by a single daily injection for 3 to 5 days by intramuscular, subcutaneous or intravenous route.
Dogs: Treatment of infected wounds and abscesses: 2 mg Marbofloxacin /kg b.w (1 ml Marbodad 2% injection /10 kg b.w) by a single subcutaneous injection. This should be followed by oral administration of Marbofloxacin tablets.
Treatment of infections of lower urinary tract: 4 mg Marbofloxacin /kg b.w (2 ml Marbodad 2% injection /10 kg b.w) for 4 days.
Prevention of surgical infections: 2 mg Marbofloxacin /kg b.w (1 ml Marbodad 2% injection /10 kg b.w) by a single intravenous injection, just before the intervention.
Cats: Treatment of infected wounds and abscesses: 2 mg Marbofloxacin /kg b.w (0.5 ml Marbodad 2% injection /5 kg b.w) by a single subcutaneous injection for 3 to 5days.
Prevention of surgical infections: 2 mg Marbofloxacin / kg b.w (0.5 ml Marbodad 2% injection /5 kg b.w) by a single intravenous injection, just before the intervention.
Contra-indications: Do not administer in animals with known hypersensitivity to Fluoroquinolones, or to any of the excipients of the product. It growing pups of large or very large breeds, articular impairments (erosion of the articular cartilage) may appear during prolonged treatments with Fluoroquinolones.
In medium-sized growing dogs marbofloxacin is well tolerated up to doses of 4 mg/ kg/day administrated during 13 weeks. However, it is not advised to administer the veterinary medicinal product to pups of large breeds up to the age of 12 and 18 months respectively.
Overdose:
- Over dosage may cause signs such as acute neurological disorders which should be treated symptomatically.
- Bradycardia could also be observed in cats and dogs.
Adverse reactions:
- No severe side-effects to be expected at doses up to 3 to 5 time the recommended dose in calves.
- Occasionally, the subcutaneous and intramuscular use of the product in calves may be associated with pain and localised inflammatory reaction without clinical impact.
- In cats and dogs, neurological sings (seizures, ataxia, mydriasis, muscle tremor), digestive signs ( hypersalivation, emesis) and reactions at the injection site have been recorded after treatment on very rare occasions. In case of severe reaction, symptomatic treatment must be initiated.
Withdrawal Period: Calves: Meat and offal: 4 days.
Storage: Store in dry place below 30°C, protect from light, Don't refrigerate.
For Veterinary Use Only
Manufactured in Jordan
